General Info

Established in 1994, EnColl Corp., manufactures and markets Type-I collagen-based products addressing the needs of plastic surgery, orthopedic surgery, oral surgery, neurological injuries, drug delivery, biopharmaceutical research and cosmetic as well as veterinary applications. The company's product line includes surgical products and implants, gene therapy, skin care and dietary products. EnColl Corp has expertise in biomaterials medical devices area and cell-culture activities. Its patented surface modified or energized collagen, CollagenPRO, can be used for biomedical applications. This technology is used to develop advanced biotech products.